In the Curtis dataset, SLC2A3 mRNA expression was observed 2.665-fold decrease in invasive lobular breast carcinoma samples, while SLC2A4 downregulation was found in invasive breast carcinoma samples with a fold change of 5.226 from TCGA Breast dataset[22]. Here, SLC2A3 is linked to invasive breast carcinoma.